Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naïve patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study-Reference-Cited by-同舟云学术

Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naïve patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study

Published:2012-06-27 Issue:6 Volume:72 Page:844-850
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Detert Jacqueline,Bastian Hans,Listing Joachim,Weiß Anja,Wassenberg Siegfried,Liebhaber Anke,Rockwitz Karin,Alten Rieke,Krüger Klaus,Rau Rolf,Simon Christina,Gremmelsbacher Eva,Braun Tanja,Marsmann Bettina,Höhne-Zimmer Vera,Egerer Karl,Buttgereit Frank,Burmester Gerd-R

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of adalimumab combined with Tripterygium wilfordii Hook F in the treatment of patient with rheumatoid arthritis: A multicenter, open‐label, randomized‐controlled trial;International Journal of Rheumatic Diseases;2024-01

2. Initial Treatment with Biological Therapy in Rheumatoid Arthritis;Journal of Clinical Medicine;2023-12-21

3. Exploring the role of gut microbiota in advancing personalized medicine;Frontiers in Microbiology;2023-11-30

4. Fluorescence optical imaging feature selection with machine learning for differential diagnosis of selected rheumatic diseases;Frontiers in Medicine;2023-08-21

5. Drug retention of biologics and Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study;RMD Open;2023-08